CARLSBAD, Calif. (AP) _ GenMark Diagnostics Inc. (GNMK) on Thursday reported a loss of $3.7 million in its fourth quarter.

The Carlsbad, California-based company said it had a loss of 5 cents per share.

The results did not meet Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 1 cent per share.

The molecular diagnostics company posted revenue of $50.1 million in the period.

For the year, the company reported that its loss narrowed to $18.6 million, or 28 cents per share. Revenue was reported as $171.6 million.

GenMark Diagnostics expects full-year revenue in the range of $188 million to $198 million.

GenMark Diagnostics shares have climbed 29% since the beginning of the year. In the final minutes of trading on Thursday, shares hit $18.80, increasing fivefold in the last 12 months.

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on GNMK at https://www.zacks.com/ap/GNMK

Copyright by Automated Insights, Inc. All rights reserved., source Associated Press News